✦ LIBER ✦

HE1 COST-EFFECTIVENESS OF 1ST LINE CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER AMONG PATIENTS RECEIVING CARE IN THE OUTPATIENT COMMUNITY SETTING

✍ Scribed by JR Hoverman; G Pohl; SK Gruschkus; M Marciniak; M Forsyth; G Peltz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN41 ECONOMIC OUTCOMES AMONG 2ND LINE N

✍ S Gruschkus; C Reyes; M Forsyth; A Ravelo; E Nadler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

CN4 COST MINIMISATION ANALYSIS OF FIRST

✍ R Launois; K Le Lay; L Riou França; S Avoinet; N Chemali; A Vergnenegre 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PCN6: MODELLING THE COST-EFFECTIVENESS O

✍ P Sharplin; UK Bose; J Holmes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PCN23 A COST MINIMIZATION ANALYSIS OF FI

✍ K Le Lay; L Riou-França; S Avoinet; N Chemali; A Vergnenègre; R Launois 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

The cost-effectiveness of navelbine alon

✍ W.K. Evans; T. Le Chevalier 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 821 KB

A comparison of individualized treatment

✍ Nelson, Richard E.; Stenehjem, David; Akerley, Wallace 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 815 KB